SIS
MREO

Sound Income Strategies’s Mereo BioPharma MREO Stock Holding History

Sound Income Strategies’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66
Closed -$22 – 1661
2026
Q1 		$22 Buy
+66
New +$28 ﹤0.01% 2557

Other funds holding MREO

SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
APA
Astoria Portfolio Advisors New York $593M AUM 28.97% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
NECFA
New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sound Income Strategies's MREO Position: Q2 2026 in Review

Sound Income Strategies sold out of Mereo BioPharma (MREO) in Q2 2026, closing a stake of 66 shares — an estimated $22 sold.

Sound Income Strategies first reported a position in MREO in Q1 2026 and held it in 1 quarter. The position peaked at $22 in Q1 2026. 9 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Sound Income Strategies reported no remaining Mereo BioPharma position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 66 Mereo BioPharma shares in Q2 2026, an estimated $22.
  • Sound Income Strategies first reported a position in Mereo BioPharma in Q1 2026 and held it in 1 quarter.
  • Sound Income Strategies's Mereo BioPharma position peaked at $22 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.